Cardiovascular disease and toxicities related to HIV infection and its therapies

Author： Zareba Karolina M   Miller Tracie L   Lipshultz Steven E  

Publisher： Informa Healthcare

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.4, Iss.6, 2005-11, pp. : 1017-1025

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

HIV-Related Cardiovascular Disease and Drug Interactions

By Kinjal A. Nanavati  

American Journal of Cardiovascular Drugs, Vol. 4, Iss. 5, 2004-01 ,pp. : 315-324

Adis International

Access to resources Recommend Favorite

Cardiovascular Disease and Therapeutic Drug-Related Cardiovascular Consequences in HIV-Infected Patients

By Fisher Stacy D.  

American Journal of Cardiovascular Drugs, Vol. 11, Iss. 6, 2011-12 ,pp. : 383-394

Adis International

Access to resources Recommend Favorite

Antiretroviral therapies in HIV-1 infection

By Morris-Jones S.   Moyle G.   Easterbrook P.J.  

Expert Opinion on Investigational Drugs, Vol. 6, Iss. 8, 1997-08 ,pp. : 1049-1062

Informa Healthcare

Access to resources Recommend Favorite

Cryptococcal disease and HIV infection

By Waters Laura   Nelson Mark  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 15, 2005-12 ,pp. : 2633-2644

Informa Healthcare

Access to resources Recommend Favorite

Investigational Notch and Hedgehog inhibitors – therapies for cardiovascular disease

By Redmond Eileen M   Guha Shaunta   Walls Dermot   Cahill Paul A  

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 12, 2011-12 ,pp. : 1649-1664

Informa Healthcare

Access to resources Recommend Favorite